VTE

Related by string. VTEs * * VTE prophylaxis . symptomatic VTE . venous thromboembolism VTE . recurrent VTE . VTE prevention . Venous thromboembolism VTE . Venous Thromboembolism VTE . venous thromboembolism VTE prophylaxis *

Related by context. All words. (Click for frequent words.) 79 venous thromboembolism 75 venous thromboembolism VTE 73 venous thrombosis 68 thromboembolism 67 venous blood clots 66 cardiovascular disease CVD 66 thrombotic events 66 DVT 65 thromboembolic events 65 thrombosis 65 thromboembolic 64 myocardial infarction MI 64 acute coronary syndrome 64 thromboses 64 cardiovascular mortality 63 DVT PE 63 thromboprophylaxis 63 reinfarction 63 recurrent VTE 62 fragility fracture 62 atherothrombotic disease 62 thromboembolic complications 62 venous thromboembolisms 62 ADHF 62 macrovascular events 61 nonfatal MI 61 myocardial infarction 61 perioperative mortality 61 upper gastrointestinal bleeding 61 venous thromboembolic events 61 atherothrombosis 61 VTE prophylaxis 61 pulmonary embolism PE 61 CMV disease 61 vertebral fracture 61 definite stent thrombosis 61 nonvertebral fractures 61 osteoporotic fractures 60 deep vein thrombosis 60 ipsilateral stroke 60 recurrent DVT 60 recurrent venous thromboembolism 60 acute coronary syndromes 60 acute coronary 60 rivaroxaban 60 postoperative AF 60 atherothrombotic events 60 stable angina 59 venous thromboembolic disease 59 hemorrhagic complications 59 vertebral fractures 59 statin therapy 59 unstable angina 59 ximelagatran 59 acute myocardial infarction AMI 59 enoxaparin 59 myocardial infarction stroke 59 post thrombotic syndrome 59 clopidogrel 59 postoperative atrial fibrillation 59 ischemic stroke 59 carotid stenosis 59 XIENCE V PROMUS Stent 59 intracerebral hemorrhage 59 cirrhotic patients 59 cardiovascular hospitalization 59 prostate cancer CaP 59 MACCE 59 COPD 58 Pulmonary embolism 58 fragility fractures 58 symptomatic VTE 58 subclinical hypothyroidism 58 Venous thromboembolism 58 thromboembolic disease 58 severe sepsis 58 periprocedural 58 contralateral breast cancer 58 NSTE ACS 58 β blockers 58 ARIXTRA 58 DVTs 58 coronary revascularization 58 recurrent ischemia 58 ischemic cardiomyopathy 58 patients undergoing CABG 58 nonfatal stroke 58 DVT blood clot 58 revascularization procedures 58 cardiovascular disease 58 rebleeding 58 asthma exacerbations 58 nonvertebral fracture 58 CMV infection 58 invasive breast cancer 58 venous thromboembolic 58 ECG abnormalities 58 atherothrombotic 58 hip fractures 58 repeat revascularization 58 noncardiac surgery 58 antibiotic prophylaxis 58 contrast induced nephropathy 57 postoperative mortality 57 asymptomatic 57 recurrent stroke 57 advanced adenomas 57 MIs 57 ST elevation myocardial 57 invasive candidiasis 57 invasive aspergillosis 57 acid suppressive medication 57 colorectal adenomas 57 ruptured aneurysms 57 hip fracture 57 antiplatelet therapy 57 subtrochanteric 57 hyperkalemia 57 deep venous thrombosis 57 atrial fibrillation 57 cerebrovascular events 57 colorectal adenoma 57 NSTEMI 57 cardiovascular morbidity 57 osteoporotic fracture 57 syncopal 57 HF hospitalization 57 antithrombotic therapy 57 cerebral microbleeds 57 nonmelanoma skin cancer 57 PONV 57 ICD implantation 57 knee OA 57 tamsulosin 57 carotid endarterectomy 57 beta blocker therapy 57 atherosclerotic disease 57 carotid endarterectomy CEA 57 colorectal cancer 57 nonfatal myocardial infarction 56 postoperative pulmonary 56 proximal DVT 56 Deep Vein Thrombosis DVT 56 NATRECOR R 56 endophthalmitis 56 TAVR 56 colectomy 56 arterial thromboembolism 56 thrombotic complications 56 anaphylactic episodes 56 virologic failure 56 CVD mortality 56 variceal bleeding 56 pericardial effusion 56 spontaneous preterm birth 56 severe aortic stenosis 56 OAB symptoms 56 anticoagulant therapy 56 severe hypoglycemic 56 arterial thromboembolic events 56 nonadherence 56 Erythropoietic therapies may 56 BSIs 56 PRADAXA 56 atrial fibrillation AF 56 MetS 56 systemic embolism 56 inhospital 56 nonfasting triglyceride levels 56 CHD CVD 56 COPD exacerbations 56 acute coronary syndromes ACS 56 herpes zoster 56 URTI 56 recurrent myocardial infarction 56 locoregional 56 cardioembolic stroke 56 postoperative infections 56 CRBSI 56 coronary artery disease 56 ocular toxicity 56 candidemia 56 DAPT 56 ankylosing spondylitis AS 56 stent thrombosis 56 symptomatic pulmonary embolism 56 adenoma 56 HeFH 56 DVT blood clots 56 ALCL 56 noncardiovascular 56 silent ischemia 56 spontaneous preterm delivery 56 Venous Thromboembolism 56 severe exacerbations 56 subclinical hyperthyroidism 56 microalbuminuria 56 ischemic strokes 56 cerebral vasospasm 56 Venous Thromboembolism VTE 56 distant metastases 56 CDAD 56 EBRT 56 cerebral infarction 55 blood clots 55 pulmonary embolisms 55 aldosterone antagonist 55 hepatocellular carcinoma HCC 55 cryptogenic stroke 55 dyslipidaemia 55 postoperative complications 55 myocardial infarctions 55 arterial thrombosis 55 breast cancer recurrence 55 osteoporotic 55 severe asthma exacerbations 55 antithrombotics 55 chlamydial infection 55 knee osteoarthritis OA 55 ezetimibe simvastatin 55 hip BMD 55 CVD 55 perioperative complications 55 urolithiasis 55 CYPHER Stent 55 coronary heart 55 LOVENOX 55 malignant neoplasms 55 Prehypertension 55 empyema 55 postoperative morbidity 55 VTEs 55 infective endocarditis 55 nonfatal cardiovascular 55 CaP 55 alemtuzumab treated 55 lipid lowering therapy 55 warfarin therapy 55 elevated CRP 55 postoperative delirium 55 posaconazole 55 LV dysfunction 55 deep vein thromboses 55 invasive fungal infection 55 CHD 55 rosuvastatin 55 bisphosphonate therapy 55 androgen deprivation 55 GI bleeding 55 thrombophilia 55 ticagrelor 55 Contrast Induced Nephropathy CIN 55 superficial vein thrombosis 55 pulmonary emboli 55 SLNB 55 platelet reactivity 55 angiographic restenosis 55 tiotropium 55 DES implantation 55 antimicrobial prophylaxis 55 cardiovascular hospitalizations 55 biochemical recurrence 55 intravenous bisphosphonates 55 Thrombolysis 55 eplerenone 55 Acute Coronary Syndromes ACS 55 infarction STEMI 55 rehospitalization 55 carotid plaque 55 IPAH 55 fatal myocardial infarction 55 T2DM 55 preterm delivery 55 rectal carcinoma 55 eptifibatide 55 COPD exacerbation 55 Events MACE 55 refractory ischemia 55 extrapyramidal symptoms 55 postoperative complication 55 Stent thrombosis 55 chemoradiotherapy 55 VT VF 55 dronedarone 55 polyp recurrence 55 unstable angina pectoris 55 composite endpoint 54 nonvertebral 54 gouty arthritis 54 GERD 54 clinically localized prostate 54 carotid artery disease 54 postmenopausal breast cancer 54 distal colon cancer 54 events MACE 54 serum phosphate 54 recurrent atrial fibrillation 54 Taxus Stent 54 paroxysmal AF 54 colorectal cancer CRC 54 GnRH agonists 54 neurologic complications 54 dabigatran etexilate 54 advanced adenoma 54 AFib 54 NATRECOR ® 54 ARCOXIA 54 interstitial pneumonia 54 ATACAND 54 candesartan 54 mammographic density 54 hepatocellular carcinoma 54 cilostazol 54 chemoradiation 54 rFVIIa 54 gastric cancer 54 abdominal adiposity 54 pelvic lymphadenectomy 54 oral diclofenac 54 dysglycemia 54 bosentan 54 periprocedural MI 54 antiplatelet agents 54 adrenal insufficiency 54 basal cell carcinoma BCC 54 febrile neutropenia 54 ticlopidine 54 tumor recurrence 54 Exacerbations 54 bacterial prostatitis 54 recurrent miscarriage 54 coronary revascularization procedures 54 left ventricular dysfunction 54 mycophenolate mofetil 54 locoregional recurrence 54 TEAEs 54 PHPT 54 TAXUS Express Stent 54 perioperatively 54 hypertensive patients 54 baseline HbA1c 54 gallstone disease 54 advanced hepatocellular carcinoma 54 hemorrhagic strokes 54 ESRD patients 54 severe hypoglycemia 54 femoral neck fracture 54 NAFLD 54 D dimer 54 atypical fractures 54 PPIs 54 pulmonary embolism 54 anticoagulation therapy 54 carotid artery blockage 54 fondaparinux 54 cerebrovascular accidents 54 intracerebral haemorrhage 54 carotid artery narrowing 54 perinatal mortality 54 aspirin therapy 54 CABG 54 LVEF 54 CYPHER ® Stent 54 coronary disease 54 pCR 54 arterial thrombotic 54 HSCT 54 androgen deficiency 54 octreotide LAR 54 chronic rhinosinusitis 54 asthma exacerbation 54 amenorrhoea 54 aldosterone antagonists 54 tamoxifen therapy 54 asymptomatic AF 54 UA NSTEMI 54 revascularisation 54 macrovascular 54 RE LY ® 54 bone metastases 54 KIF6 carriers 54 acute cholecystitis 54 asymptomatic PAD 54 solifenacin 54 Peripheral arterial disease 54 non valvular atrial 54 endometrial hyperplasia 54 prophylaxis 54 salmeterol HFA MDI 54 myocardial infarctions MIs 54 binary restenosis 54 Coronary Artery Bypass Graft 54 chronic periodontitis 54 ductal cancer 54 myocardial ischemia 54 symptomatic BPH 54 paclitaxel eluting stents 54 thrombotic 54 GP IIb IIIa inhibitors 54 systolic dysfunction 54 carotid IMT 54 SREs 54 endometrial carcinoma 54 undergoing coronary angiography 54 HbA 1c levels 53 Acute Coronary Syndrome 53 S. aureus infections 53 hemodialysis patients 53 nonischemic 53 intracranial hemorrhage ICH 53 atrophic gastritis 53 STEMI patients 53 lipid lowering drugs 53 unfractionated heparin 53 Febrile neutropenia 53 nonfatal myocardial infarction MI 53 treatment emergent adverse 53 incontinence episodes 53 antiplatelet medications 53 BRCA2 mutation carriers 53 noncardiac 53 atypical femur fractures 53 spine fractures 53 colorectal liver metastases 53 renal impairment 53 pathologic fractures 53 subclinical atherosclerosis 53 HbA1c levels 53 soft tissue sarcomas 53 imipenem 53 prostate cancer CRPC 53 de ath 53 pre menopausal 53 acute myocardial infarctions 53 antiplatelet medication 53 Sudden Cardiac Death 53 pretest probability 53 osteoporotic vertebral fractures 53 acetabular dysplasia 53 glucocorticoid induced osteoporosis 53 Deep vein thrombosis 53 neonatal morbidity 53 Obstructive Sleep Apnea 53 nephron sparing surgery 53 coronary intervention 53 intracranial aneurysms 53 adenomatous polyps 53 DVT prophylaxis 53 bivalirudin 53 carotid artery stenosis 53 lacunar 53 pharyngeal cancer 53 bacteremia 53 coronary artery calcification 53 comorbidities 53 peritoneal cancer 53 secondary hyperparathyroidism 53 STRIDE PD 53 sudden cardiac death 53 TORISEL 53 adenoma recurrence 53 valsartan 53 comorbid conditions 53 rotavirus diarrhea 53 ASCUS 53 NNT = 53 ALT flares 53 HIV HCV coinfected 53 revascularization 53 colorectal neoplasia 53 endometrial cancer 53 percutaneous coronary interventions 53 dose aspirin 53 Hip fracture 53 EXJADE 53 lipid lowering agents 53 BENICAR HCT 53 hypercalcemia 53 LVSD 53 hormone therapy HT 53 STEMI 53 DU #b 53 nonobstructive CAD 53 renal dysfunction 53 noncarriers 53 breast abscesses 53 renal insufficiency 53 Unstable Angina 53 postpartum hemorrhage 53 anastomotic leak 53 CYPHER R Stent 53 cardiovascular 53 troponin T 53 TMP SMX 53 idraparinux 53 APTIVUS r 53 atypical antipsychotic medications 53 carotid artery stenting CAS 53 elevated triglyceride levels 53 AUDs 53 eosinophilic pneumonia 53 familial AF 53 cardiac dysfunction 53 undergoing radical prostatectomy 53 XIENCE V demonstrated 53 revascularizations 53 nesiritide 53 lumiracoxib 53 adjuvant therapy 53 invasive coronary angiography 53 bone metastasis 53 stent thromboses 53 acute myocardial infarction 53 dual antiplatelet therapy 53 TAXUS Stent 53 ONJ 53 oral anticoagulation 53 ischemic complications 53 LUTS 53 bladder cancers 53 bacteraemia 53 invasive fungal infections 53 cutaneous melanoma 53 NSAIDs 53 chlamydia infection 53 proliferative diabetic retinopathy 53 coinfected patients 53 Thromboembolism 53 retinal vein occlusion 53 femur fractures 53 adjuvant radiotherapy 53 lumbar disc disease 53 Invasive Breast Cancer 53 stroke myocardial infarction 53 oral anticoagulant 53 endarterectomy 53 S. aureus infection 53 Subgroup analyzes 53 lipid abnormalities 53 HCV infection 53 MGUS 53 morbidity 53 RYGB 53 antiplatelet drugs 53 CDI recurrence 53 nodal metastases 52 prognostic variables 52 radical nephrectomy 52 warfarin 52 uncontrolled asthma 52 BRCA mutations 52 dyslipidemia 52 PSADT 52 dalteparin 52 postoperative infection 52 pulmonary dysfunction 52 prostate cancer PCa 52 C difficile infection 52 STEMIs 52 pulmonary resection 52 lymphadenectomy 52 P = .# 52 hypoglycemic events 52 obstructive sleep apnea 52 bronchogenic carcinoma 52 ischemic vascular 52 pleural mesothelioma 52 multivessel disease 52 heparin induced thrombocytopenia 52 pancreatectomy 52 preterm birth 52 adrenalectomy 52 metachronous 52 adenomas 52 microbleeds 52 SHPT 52 Enoxaparin 52 extracranial 52 chemoradiation therapy 52 CP CPPS 52 5-FU/LV 52 AA Amyloidosis 52 decompensated heart failure 52 bronchopulmonary dysplasia 52 Endarterectomy 52 pathologic fracture 52 carotid plaques 52 Lp PLA2 52 % CI #.#-#.# [006] 52 preoperative chemotherapy 52 Restenosis 52 ALND 52 Asymptomatic 52 thrombolytic therapy 52 nonmelanoma skin cancers 52 ADEs 52 atherogenic dyslipidemia 52 Recurrences 52 acute otitis media 52 aortic stenosis 52 BMD measurements 52 lower extremity amputation 52 glycated hemoglobin levels 52 adalimumab 52 acute STEMI 52 CYPHER R Sirolimus eluting 52 invasive cervical cancer 52 NSAID 52 ductal breast cancer 52 antithrombotic 52 salmeterol 52 CYPHER ® 52 Cypher Stent 52 carotid atherosclerosis 52 coronary 52 PAOD 52 chronic GVHD 52 Postoperative complications 52 neoadjuvant therapy 52 asymptomatic carotid stenosis 52 diabetes mellitus DM 52 undergone radical prostatectomy 52 NMIBC 52 advanced neoplasia 52 oral FTY# 52 nosocomial infection 52 PREZISTA r 52 Treatment emergent adverse 52 chronic HBV infection 52 nonoperative treatment 52 morphometric vertebral fractures 52 colorectal cancers 52 microvascular complications 52 symptomatic DVT 52 PCa 52 gastrectomy 52 ischemic cardiovascular 52 postmenopausal osteoporotic women 52 vertebral compression fractures 52 transient ischemic attacks 52 microscopic hematuria 52 T1DM 52 undergoing coronary artery 52 C. difficile diarrhea 52 Vitamin D insufficiency 52 artery stenosis 52 oophorectomy 52 gastrointestinal cancers 52 PCIs 52 angina pectoris 52 carotid artery stenting 52 LMWH 52 aortic valve stenosis 52 hypoglycaemic episodes 52 Adjuvant chemotherapy 52 liver transplant recipients 52 Heavy menstrual bleeding 52 nondiabetic patients 52 generalized edema 52 COPAXONE R 52 cinacalcet 52 Percutaneous Coronary Intervention 52 thrombocytopenic 52 duodenal ulcers 52 vasomotor symptoms 52 inflammatory lesions 52 revascularization procedure 52 diabetes mellitus 52 Kaplan Meier analysis 52 hepatectomy 52 thrombolysis 52 oncologic outcomes 52 CIN3 52 total thyroidectomy 52 Unstable angina 52 POAG 52 intensive statin therapy 52 node metastases 52 RSV infections 52 secondary efficacy endpoint 52 esophageal cancers 52 pulmonary exacerbations 52 BARI 2D 52 external genital lesions 52 symptomatic carotid stenosis 52 hypercholesterolaemia 52 confidence interval CI 52 VTE prevention 52 Clostridium difficile infections 52 radiotherapy RT 52 serum calcium levels 52 antiplatelet 52 zoledronic acid 52 brain metastases 52 systolic BP 52 Renal dysfunction 52 Major Adverse Cardiac 52 retrospective cohort 52 hepatorenal syndrome 52 bypass graft CABG surgery 52 hyperglycaemia 52 HGPIN 52 lobular breast cancer 52 fatal pulmonary embolism 52 malignant neoplasm 52 recurrent coronary 52 prospectively defined 52 menopausal hormone therapy 52 stent implantation 52 symptomatic aortic stenosis 52 peri operative 52 C. difficile colitis 52 lumbar spine BMD 52 juvenile idiopathic arthritis 52 lobular carcinoma 52 hyperglycemia 52 lipid lowering medications 52 AAT deficiency 52 atypical ductal hyperplasia 52 CHD mortality 52 anastrozole 52 femoral neck fractures 52 PASI scores 52 angiographic outcomes 52 acute myocardial infarction MI 52 BRCA2 mutations 52 cTnT levels 52 serum calcium 52 liver resection 52 bowel cancers 52 delayed CINV 52 tumor lysis syndrome 52 T2 lesions 52 S. aureus bacteremia 52 psychiatric comorbidities 52 pegylated interferon alfa 2b 52 macrovascular disease 52 gastric adenocarcinoma 52 statin 52 carotid stenting 52 disease CHD 52 atherosclerotic vascular disease 52 anal cancers 52 ventricular arrhythmia 52 ACC AHA 52 intraoperative complications 52 colorectal cancer incidence 52 hypercalciuria 52 apixaban 52 severe psoriasis 52 oxycodone CR 52 statins 52 adjuvant chemotherapy 52 fluvastatin 52 AVANDIA 52 radicular pain 52 Acute Coronary Syndromes 52 gastrointestinal GI bleeding 52 tirofiban 52 MRSA colonization 51 underwent CABG 51 nonsevere 51 IBS C 51 thyroid nodules 51 postmenopausal women 51 confidence interval #.#-#.# 51 intima media thickness 51 ALI ARDS 51 morbidity mortality 51 postdischarge 51 leiomyomas 51 insulin glargine 51 acute sinusitis 51 gestational hypertension 51 postsurgical complications 51 Nesiritide 51 exacerbations 51 lumbar disc herniation 51 biochemical relapse 51 vaginal hysterectomy 51 adjuvant therapies 51 postsurgical 51 hematuria 51 acute ischemic stroke 51 elevated ALT 51 rectal cancers 51 nosocomial infections 51 CRBSIs 51 aromatase inhibitors AIs 51 Coronary artery bypass graft 51 ICD shocks 51 landmark ATHENA trial 51 EUS FNA 51 NOLVADEX 51 RE LY 51 hepatic metastases 51 Elitek 51 Deep venous thrombosis 51 vaginal atrophy 51 Patency 51 rosiglitazone 51 CABG surgery 51 discontinuations due 51 Anticoagulation 51 Acute Myocardial Infarction AMI 51 clots 51 VWD 51 intracerebral hemorrhage ICH 51 rectal cancer 51 variceal 51 external beam radiotherapy 51 GH deficiency 51 cerebrovascular accident 51 Coronary artery disease 51 cTnT 51 CTEPH 51 anticoagulation 51 multivariable adjusted 51 nontraumatic 51 Torsades de Pointes 51 Ischemic stroke 51 chorioamnionitis 51 epithelial ovarian cancer 51 stroke transient ischemic 51 invasive pneumococcal disease 51 femoral shaft fractures 51 TAVI 51 comorbidity 51 non metastatic osteosarcoma 51 distal embolization 51 bisphosphonate 51 Aortic stenosis 51 GERD symptoms 51 lower extremity amputations 51 thrombus aspiration 51 myopathy rhabdomyolysis 51 ertapenem 51 dutasteride 51 QVAR R 51 colorectal neoplasms 51 nonoperative 51 RSV infection 51 cardiac tamponade 51 pioglitazone 51 angiographically 51 QTc prolongation 51 etiologic 51 nonfasting triglycerides 51 rotavirus gastroenteritis 51 lupus nephritis 51 hepatic resection 51 nonfatal heart 51 untreated OSA 51 endometrial cancers 51 precancerous cervical lesions 51 FOLFOX4 51 ABCB1 51 Radical prostatectomy 51 HBV infection 51 autonomic dysfunction 51 arterial calcification 51 serum phosphorous 51 neoplasia 51 lung resection 51 target vessel revascularization 51 postpartum haemorrhage 51 afib 51 serum IGF 51 hyperbilirubinemia 51 prolonged QT interval 51 SRBD 51 Myocardial infarction 51 Aprotinin 51 Acute Myeloid Leukaemia AML 51 stenoses 51 cutaneous squamous cell carcinoma 51 TZD 51 OSAHS 51 circulatory diseases 51 cardiogenic shock 51 severe neutropenia 51 postoperative radiotherapy 51 ivabradine 51 cobiprostone 51 coronary stenosis 51 deep venous thromboses 51 telmisartan 51 antiarrhythmic drug 51 metastatic disease 51 ROCKET AF 51 onset atrial fibrillation 51 preeclampsia 51 direct thrombin inhibitors 51 cSSSI 51 acid suppressive medications 51 elevated LDL cholesterol 51 HBeAg seroconversion 51 bypass grafting 51 corneal ectasia 51 stratifying patients 51 tolvaptan 51 ICD implants 51 chlorambucil 51 GISTs 51 acute aortic dissection 51 fatal IHD 51 FRAGMIN 51 IIIa inhibitor 51 alcoholic cirrhosis 51 lactic acidosis 51 precancerous colon polyps 51 Aspergillus infections 51 esophageal varices 51 QTc interval 51 acute GVHD 51 reperfusion therapy 51 conjugated equine estrogen 51 loop diuretics 51 peginterferon alfa 2a 51 cytoreductive surgery 51 adjuvant radiation 51 serum creatinine levels 51 gonococcal infection 51 percutaneous coronary intervention 51 virologic response 51 cholecystectomy 51 FluCAM arm 51 ADPKD 51 neoadjuvant 51 intermittent claudication 51 epidural steroid injections 51 VAD implantation 51 cardio vascular disease 51 glucocorticoid therapy 51 venous thrombotic events 51 grade glioma 51 pulmonary thromboembolism 51 recurrent UTI 51 clopidogrel Plavix 51 generalized seizures 51 pH#N# 51 confirmed thrombotic cardiovascular 51 MULTAQ 51 antihypertensive medications 51 stenting 51 glycoprotein IIb IIIa inhibitors 51 conventional angiography 51 Malignant Melanoma 51 artery calcification 51 multivariate Cox 51 knee osteoarthritis 51 NYHA Class II 51 recurrent genital herpes 51 anovulatory infertility 51 seasonal influenza 51 cardiovascular ischemic 51 anticoagulants 51 preoperative PSA 51 renal tumors 51 T2D 51 coronary blockages 51 paroxysmal atrial fibrillation 51 perioperative morbidity 51 pyelonephritis 51 infarctions 51 inflammatory rheumatic 51 FASLODEX 51 prescribed statins 51 Acute MI 51 haemorrhagic stroke 51 Diabetic Macular Edema 51 histologic subtype 51 Hypotension 51 canakinumab 51 lopinavir r arm 51 teriflunomide 51 peripheral arterial disease 51 Arixtra 51 hypoglycemia 51 VUR 51 cervical intraepithelial neoplasia 51 calcium supplementation 51 lobectomy 51 variceal hemorrhage 51 modifiable risk 51 thrombo embolic 51 adjunctive placebo 51 nephrotoxicity 51 MitraClip device 51 edoxaban 51 laboratory abnormalities 51 ketorolac 51 Celebrex celecoxib 51 Ranolazine 51 Relapsing Remitting Multiple Sclerosis 51 oral antidiabetic medication 51 tension pneumothorax 51 recurrent ischemic stroke 51 ß blockers

Back to home page